Blood oxygenation level-dependent MR imaging as a predictor of therapeutic response to concurrent chemoradiotherapy in cervical cancer: A preliminary experience

European Radiology

Volumn 24, Issue 7, 2014, Pages 1514-1520

  Kim, Chan Kyo ^a   Park, Sung Yoon ^a   Park, Byung Kwan ^a   Park, Won ^a   Huh, Seung Jae ^a  

^a Sungkyunkwan University School of Medicine   (South Korea)

Author keywords

Biomarker; Blood oxygenation level dependent MRI; Cervical cancer; Concurrent chemoradiotherapy; MRI

Indexed keywords

CISPLATIN; FLUORODEOXYGLUCOSE F 18; FLUOROURACIL; IRIDIUM 192; ANTINEOPLASTIC AGENT; OXYGEN;

ADULT; AGED; ARTICLE; BOLD SIGNAL; BRACHYTHERAPY; CANCER PATIENT; CANCER SIZE; CHEMORADIOTHERAPY; CLINICAL ARTICLE; COMPUTER ASSISTED EMISSION TOMOGRAPHY; COMPUTER ASSISTED RADIOTHERAPY; EXTERNAL BEAM RADIOTHERAPY; FEMALE; HUMAN; MULTIPLE CYCLE TREATMENT; MYOMETRIUM; NUCLEAR MAGNETIC RESONANCE IMAGING; NUCLEAR MAGNETIC RESONANCE SCANNER; PREDICTOR VARIABLE; PRIORITY JOURNAL; RADIOLOGICAL PARAMETERS; TREATMENT RESPONSE; UTERINE CERVIX BIOPSY; UTERINE CERVIX CANCER; BIOPSY; BLOOD; CANCER STAGING; COMPUTER ASSISTED TOMOGRAPHY; MALE; MIDDLE AGED; OXYGEN CONSUMPTION; POSITRON EMISSION TOMOGRAPHY; PREDICTIVE VALUE; PROCEDURES; TREATMENT OUTCOME; UTERINE CERVICAL NEOPLASMS;

ADULT; AGED; ANTINEOPLASTIC AGENTS; BIOPSY; BRACHYTHERAPY; CHEMORADIOTHERAPY; FEMALE; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; NEOPLASM STAGING; OXYGEN; OXYGEN CONSUMPTION; POSITRON-EMISSION TOMOGRAPHY; PREDICTIVE VALUE OF TESTS; RADIOTHERAPY, CONFORMAL; TOMOGRAPHY, X-RAY COMPUTED; TREATMENT OUTCOME; UTERINE CERVICAL NEOPLASMS;

EID: 84902322553     PISSN: 09387994     EISSN: 14321084     Source Type: Journal    
DOI: 10.1007/s00330-014-3167-0     Document Type: Article

References (29)

1. Eisenhauer EA, Therasse P, Bogaerts J et al (2009) New response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1). Eur J Cancer 45:228-247
2. Pickles MD, Gibbs P, Lowry M, Turnbull LW (2006) Diffusion changes precede size reduction in neoadjuvant treatment of breast cancer. Magn Reson Imaging 24:843-847 (Pubitemid 44205378)
3. Britten RA, Evans AJ, Allalunis-Turner MJ, Franko AJ, Pearcey RG (1996) Intratumoral heterogeneity as a confounding factor in clonogenic assays for tumour radioresponsiveness. Radiother Oncol 39:145-153 (Pubitemid 26151460)
4. Fyles A, Milosevic M, Hedley D et al (2002) Tumor hypoxia has independent predictor impact only in patients with node-negative cervix cancer. J Clin Oncol 20:680-687 (Pubitemid 34111374)
5. Bentzen L, Keiding S, Nordsmark M et al (2003) Tumour oxygenation assessed by 18 F-fluoromisonidazole PET and polarographic needle electrodes in human soft tissue tumours. Radiother Oncol 67:339-344 (Pubitemid 36831089)
6. Mayer A, Hockel M, Vaupel P (2006) Endogenous hypoxia markers in locally advanced cancers of the uterine cervix: reality or wishful thinking? Strahlenther Onkol 182:501-510 (Pubitemid 44316238)
7. Loncaster JA, Carrington BM, Sykes JR et al (2002) Prediction of radiotherapy outcome using dynamic contrast enhanced MRI of carcinoma of the cervix. Int J Radiat Oncol Biol Phys 54:759-767
8. Neugarten J (2012) Renal BOLD-MRI and assessment for renal hypoxia. Kidney Int 81:613-614
9. Halle C, Andersen E, Lando M et al (2012) Hypoxia-induced gene expression in chemoradioresistant cervical cancer revealed by dynamic contrast-enhanced MRI. Cancer Res 72:5285-5295
10. Andersen EK, Hole KH, Lund KV et al (2013) Pharmacokinetic parameters derived from dynamic contrast enhanced MRI of cervical cancers predict chemoradiotherapy outcome. Radiother Oncol 107:117-122
11. Hallac RR, Ding Y, Yuan Q et al (2012) Oxygenation in cervical cancer and normal uterine cervix assessed using blood oxygenation level-dependent (BOLD) MRI at 3 T. NMR Biomed 25:1321-1330
12. Oh D, Lee JE, Huh SJ et al (2013) Prognostic significance of tumor response as assessed by sequential 18 F-fluorodeoxyglucose-positron emission tomography/computed tomography during concurrent chemoradiation therapy for cervical cancer. Int J Radiat Oncol Biol Phys 87:549-554
13. Vaupel P, Mayer A (2007) Hypoxia in cancer: significance and impact on clinical outcome. Cancer Metastasis Rev 26:225-239 (Pubitemid 47101660)
14. Wakefield JC, Downey K, Kyriazi S, deSouza NM (2013) New MR techniques in gynecologic cancer. AJR Am J Roentgenol 200:249-260
15. Hoskin PJ, Carnell DM, Taylor NJ et al (2007) Hypoxia in prostate cancer: correlation of BOLD-MRI with pimonidazole immunohistochemistry-initial observations. Int J Radiat Oncol Biol Phys 68:1065-1071 (Pubitemid 47048571)
16. Chen CM, Hou BL, Holodny AI (2008) Effect of age and tumor grade on BOLD functional MR imaging in preoperative assessment of patients with glioma. Radiology 248:971-978
17. Jiang L, Weatherall PT, McColl RW, Tripathy D, Mason RP (2013) Blood oxygenation level-dependent (BOLD) contrast magnetic resonance imaging (MRI) for prediction of breast cancer chemotherapy response: a pilot study. J Magn Reson Imaging 37:1083-1092
18. O'Connor JP, Naish JH, Parker GJ et al (2009) Preliminary study of oxygen-enhanced longitudinal relaxation in MRI: a potential novel biomarker of oxygenation changes in solid tumors. Int J RadiatOncol Biol Phys 75:1209-1215
19. Nam H, Huh SJ, Ju SG et al (2012) 18 F-fluorodeoxyglucose positron emisson tomography/computed tomography guided conformal brachytherapy for cervical cancer. Int J Radiat Oncol Biol Phys 84:e29-e34
20. Kim HS, Kim CK, Park BK, Huh SJ, Kim B (2013) Evaluation of therapeutic response to concurrent chemoradiotherapy in patients with cervical cancer using diffusion-weighted MR imaging. J Magn Reson Imaging 37:187-193
21. Min JH, Kim CK, Park BK, Kim E, Kim B (2011) Assessment of renal lesions with blood oxygenation level-dependent MRI at 3 T: preliminary experience. AJR Am J Roentgenol 197:W489-W494
22. Prasad PV (2006) Evaluation of intra-renal oxygenation by BOLD MRI. Nephron Clin Pract 103:c58-c65
23. Lyng H, Sundfor K, Trope C, Rofstad EK (2000) Disease control of uterine cervical cancer: relationships to tumor oxygen tension, vascular density, cell density, and frequency of mitosis and apoptosis measured before treatment and during radiotherapy. Clin Cancer Res 6:1104-1112 (Pubitemid 30159373)
24. Hockel M, Schlenger K, Hockel S, Vaupel P (1999) Hypoxic cervical cancers with low apoptotic index are highly aggressive. Cancer Res 59:4525-4528 (Pubitemid 29428951)
25. Harry VN (2010) Novel imaging techniques as response biomarkers in cervical cancer. Gynecol Oncol 116:253-261
26. Li LP, Halter S, Prasad PV (2008) Blood oxygen level-dependent MR imaging of the kidneys. Magn Reson Imaging Clin N Am 16:613-625, viii
27. Wagenaar HC, Trimbos JB, Postema S et al (2001) Tumor diameter and volume assessed by magnetic resonance imaging in the prediction of outcome for invasive cervical cancer. Gynecol Oncol 82:474-482 (Pubitemid 32826447)
28. Nam H, Park W, Huh SJ et al (2007) The prognostic significance of tumor volume regression during radiotherapy and concurrent chemoradiotherapy for cervical cancer using MRI. Gynecol Oncol 107:320-325 (Pubitemid 47575732)
29. Saida T, Tanaka YO, Ohara K et al (2010) Can MRI predict local control rate of uterine cervical cancer immediately after radiation therapy? Magn Reson Med Sci 9:141-148